Insider Trading History of Marshall Paul

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Marshall Paul since 2012. The trader's CIK number is 1383994. At the time of the last reporting, Marshall Paul was the SVP, Operations of Heron Therapeutics, Inc. /de/. (stock ticker symbol HRTX). Also see all insider trading activities at Heron Therapeutics, Inc. /de/.

Note that in the past Marshall Paul also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Amylin Pharmaceuticals Inc (AMLN) by Marshall Paul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 AMLN 0 $0 5,638 $96,015 0 $0

Yearly summary of insider trading at Heron Therapeutics, Inc. /de/ (HRTX) by Marshall Paul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 HRTX 0 $0 0 $0 1,100 $9,955
2015 HRTX 0 $0 70,000 $1,043,000 71,100 $667,955


Insider trading activities at 2 companies by Marshall Paul:

1. Amylin Pharmaceuticals Inc (AMLN)

2. Heron Therapeutics, Inc. /de/ (HRTX)

Table 1. Insider trading of Amylin Pharmaceuticals Inc (AMLN) by Marshall Paul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-02-23 AMLN Sale 5,638 17.03 96,015

Table 2. Insider trading of Heron Therapeutics, Inc. /de/ (HRTX) by Marshall Paul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-03-21 HRTX Option Ex 1,100 9.05 9,955
2015-12-29 HRTX Option Ex 1,100 9.05 9,955
2015-03-05 HRTX Sale 70,000 14.90 1,043,000
2015-03-05 HRTX Option Ex 70,000 9.40 658,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Marshall Paul (SVP, Operations of Heron Therapeutics, Inc. /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.